ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1010

Eliminating Routine Post-Dialysis Serum Urea Nitrogen Measurements in Hemodialysis: Testing a Proposed Method Using Conductivity Dialyzer Clearance to Determine Protein Catabolic Rate

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Howard, John, University of California Davis Medical Center, Sacramento, California, United States
  • Chin, Andrew I., University of California Davis Medical Center, Sacramento, California, United States
Background

Traditionally, pre and post-HD BUN measurements are used to determine Kt/V and normalized protein catabolic rate (PCRn). Timing and care of post-HD BUN sampling is critical for results to be accurate. A method of estimating PCRn without the post-HD BUN, utilizing conductivity clearance and only a pre-HD BUN, has recently been proposed. We tested this method in a cohort of patients in which online conductivity clearance monitoring (OCM) and clearance by usual formal kinetic modeling were measured.

Methods

We used a retrospective cohort of 39 patients totaling 271 HD treatments during which OCM and routine monthly laboratory tests with formal kinetic modeling for Kt/V and PCRn were performed. Data (including residual renal function) were entered into the Solute-Solver® version 2.11 online 2-pool kinetic modeling program. For volume of distribution of urea (V), we tested 3 values for each treatment: 1) average of 6 months prior kinetic model V; 2) Watson formula estimated V; and 3) Chertow formula estimated V. Output data of interest included the estimated post-HD BUN, spKt/V and PCRn based on these estimated values.

Results

The spKt/V by OCM underestimated that of formal kinetic modeling with a mean difference of 0.40, primarily driven by difference in V. The overall correlation of spKt/V was modest. Using pre-HD BUN with OCM to estimate PCRn as proposed by Daugirdas, we found a good correlation between PCRn by kinetic modeling and OCM method (Fig 1).

Conclusion

In this retrospective evaluation, the method using OCM without a post-HD BUN, as proposed by Daugirdas, appears to adequately estimate PCRn. The post-HD blood draw, subject to inaccuracies due to improper sampling technique, is potentially problematic in traditional determinations of HD adequacy and calculation of PCRn. OCM based calculations of Kt/V and PCRn remove this potential source of error. This process has practical applications and should be further validated.

Funding

  • Clinical Revenue Support